Replies to post #181313 on Innovation Pharmaceuticals Inc (IPIX)

[TheHound]

Between the subjects already enrolled and those presently in screening, we have reached approximately 70% of the anticipated subjects. Subject recruitment was slower than projected due to competitive trials. In response, we have added additional investigator sites. The Company expects interim analysis top-line results in the third quarter of calendar 2017.